migraine headache. Migraine
Conditions
Interventions
Intervention 1: In case group the patients received 2 mg granicetrone single dose intravenously. Intervention 2: In control group the patients received 10 mg metoclopramide single dose intravenously.
Treatment - Drugs
In case group the patients received 2 mg granicetrone single dose intravenously
In control group the patients received 10 mg metoclopramide single dose intravenously
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: Patients older than 18 presenting with migraine headache to sina and rasool akram emergency; Have a previous history of migraine headache which was diagnosed by a neurologist; Not being pregnant; No breast feeding; No history of psychiatric disorder in the patient or first degree relatives exclusion criteria: Patient's incoopration; Headache's charectristics is different from previus attacks; Sudden oncet headache; Abnormal neurologic exam; uncertainity in diagnosis; Head trauma in the previous month
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of nausea and vomiting episodes. Timepoint: Before, 1, 2, 4 hours after intervention. Method of measurement: Standard Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache intensity. Timepoint: Before, 1, 2, 4 hours after intervention. Method of measurement: Verbal numerical rating scale.;Adverse effects. Timepoint: Before, 1, 2, 4 hours after intervention. Method of measurement: Standard Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hasan amiri MD
Tehran university of medical sciences
Outcome results
None listed